Bank Of America Corp Lyell Immunopharma, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 168,756 shares of LYEL stock, worth $102,941. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,756

Previous 142,868 18.12%

Holding current value

$102,941

Previous $207,000 12.08%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.13 - $1.88 $29,253 - $48,669	25,888 Added 18.12%	168,756 $232,000
Q2 2024 Aug 14, 2024	SELL	$1.3 - $3.01 $99,596 - $230,605	-76,613 Reduced 34.91%	142,868 $207,000
Q1 2024 May 15, 2024	SELL	$1.71 - $3.07 $2.46 Million - $4.42 Million	-1,441,108 Reduced 86.78%	219,481 $489,000
Q4 2023 Feb 14, 2024	BUY	$1.39 - $2.35 $1.63 Million - $2.75 Million	1,170,361 Added 238.74%	1,660,589 $3.22 Million
Q2 2023 Aug 14, 2023	SELL	$1.89 - $3.86 $469,787 - $959,460	-248,565 Reduced 33.64%	490,228 $1.56 Million
Q1 2023 May 12, 2023	BUY	$1.97 - $3.58 $189,742 - $344,811	96,316 Added 14.99%	738,793 $1.74 Million
Q4 2022 Feb 10, 2023	BUY	$2.78 - $8.09 $1.09 Million - $3.18 Million	392,624 Added 157.14%	642,477 $2.23 Million
Q3 2022 Nov 14, 2022	BUY	$5.54 - $8.27 $530,067 - $791,273	95,680 Added 62.06%	249,853 $1.83 Million
Q2 2022 Aug 12, 2022	SELL	$3.68 - $6.8 $120,203 - $222,115	-32,664 Reduced 17.48%	154,173 $1.01 Million
Q1 2022 May 16, 2022	BUY	$5.05 - $7.7 $503,348 - $767,482	99,673 Added 114.35%	186,837 $943,000
Q4 2021 Feb 08, 2022	BUY	$7.13 - $15.19 $606,984 - $1.29 Million	85,131 Added 4187.46%	87,164 $675,000
Q3 2021 Nov 15, 2021	SELL	$11.0 - $17.95 $686,697 - $1.12 Million	-62,427 Reduced 96.85%	2,033 $30,000
Q2 2021 Sep 13, 2021	BUY	$15.99 - $16.89 $1.03 Million - $1.09 Million	64,460 New	64,460 $1.05 Million

Others Institutions Holding LYEL

# of Institutions

121

Shares Held

142M

Call Options Held

18.1K

Put Options Held

200

View Full List

About Lyell Immunopharma, Inc.

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $151M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

More about LYEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Lyell Immunopharma, Inc. Transaction History